CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study
- 30 November 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 49 (5), 816-825
- https://doi.org/10.1016/s0190-9622(03)01836-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Evaluation of CD4+T Cell Function In Vivo in HIV‐Infected Patients as Measured by Bacteriophage phiX174 ImmunizationThe Journal of Infectious Diseases, 2000
- Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage ΦX174 in asymptomatic HIV-1 infected patientsAIDS, 2000
- Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimenAIDS, 2000
- T CELL MEMORYAnnual Review of Immunology, 1998
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytesAIDS, 1994
- Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patientsClinical and Experimental Immunology, 1991
- Human antibody responses to bacteriophage φX 174: Sequential induction of IgM and IgG subclass antibodyClinical Immunology and Immunopathology, 1989
- Predominance of ?memory? T cells (CD4+, CDw29+) over ?naive? T cells (CD4+, CD45R+) in both normal and diseased human skinArchives of Dermatological Research, 1989
- Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseasesJournal of Clinical Investigation, 1971